Charles River Laboratories International Inc

NYSE:CRLUnited States

Charles River Laboratories International, Inc. is a full service, non-clinical contract research company. The Company provides research models required in research and development of new drugs, devices, and therapies. The Company operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment includes the research models, research model services, and research and cells solutions businesses. The DSA segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. The Manufacturing segment includes Microbial Solutions and Biologics Solutions (Biologics).

Contact Information

Headquarters

251 Ballardvale StWILMINGTON, MA, United States 01887

Phone

781-222-6000

Fax

978-988-5665

Executives

Chairman of the Board, President, Chief Executive Officer

James Foster

Corporate Executive Vice President

Flavia Pease

Chief Operating Officer, Corporate Executive Vice President

Birgit Girshick

Corporate Executive Vice President and Chief People Officer

Victoria Creamer

Corporate Executive Vice President, Chief Commercial Officer

William Barbo